Sort
172,184 grants matching “inflammation”
Targeted Anti-IL-1β Platelet Mimetics for Cardiac Detoxification and Repair
$726,966Ke Cheng · North Carolina State University Raleigh · R01 · FY2020 · HL
Survival and potential of insulin-deficient beta cells in type 1 diabetes
$726,966Desmond Arthur Schatz · University Of Florida · U01 · FY2022 · DK
Chromatin remodeling factors and mechanisms in diabetic microvascular complications
$726,922Rama Natarajan · Beckman Research Institute/City Of Hope · R01 · FY2025 · DK
Partial Antagonists of IRE1 RNaseâÂÂâÂÂPAIRâÂÂsâÂÂto treat Type 1 Diabetes
$726,915Feroz R Papa · University Of California, San Francisco · U01 · FY2021 · DK
Complications of Immunosuppression for Eye Diseases
$726,910John H. Kempen · University Of Pennsylvania · R01 · FY2012 · EY
Dual drug delivery to lung/blood interface in respiratory infections.
$726,891Vladimir R Muzykantov · University Of Pennsylvania · R01 · FY2022 · HL
Epidemiology: Oxidative Stress and Early Atherosclerosis
$726,884David R Jacobs · University Of Minnesota · R01 · FY2012 · HL
GUARD: A global unbiased antimicrobial discovery platform
$726,867Arul Jayaraman · Texas Engineering Experiment Station · R01 · FY2025 · AI
The role of adverse social-biological interactions in acute myeloid leukemia disparities
$726,828Irum Khan · Northwestern University At Chicago · R01 · FY2025 · CA
Novel Methods to Assess the Effects of Chemicals on Child Development
$726,773Susan L Schantz · University Of Illinois At Urbana-Champaign · P01 · FY2015 · ES
Structure Function of CB1 Cannabinoid Receptor
$726,665Raymond C Stevens · University Of Southern California · R01 · FY2016 · DA
Functional impact of IL33 polymorphisms on asthma & other Th2-mediated diseases
$726,656Kathleen C Barnes · Johns Hopkins University · R01 · FY2014 · HL
Immunometabolic impact of stress hyperglycemia on tuberculosis treatment outcomes and risk of diabetes mellitus
$726,653Matthew James Magee · Emory University · R01 · FY2023 · AI
Novel Innate and Adaptive Immunity Pathways Lead to Human Systemic Autoimmunity
$726,556Maria Virginia Pascual · Baylor Research Institute · U19 · FY2014 · AI
Immunologic and Fat-Associated Predictors of Insulin Resistance in Treated HIV
$726,542Suneil Krishna Koliwad · University Of California, San Francisco · R01 · FY2021 · DK
Advancing the development of a novel class of small molecules for treating pan-coronavirus infections
$726,503Shirit Einav · Stanford University · R01 · FY2024 · AI
Cardiac microstructure and the immune-inflammatory response to SARS-CoV-2
$726,465Susan Cheng · Cedars-Sinai Medical Center · R01 · FY2024 · HL
Modeling intra- and inter-cellular networks for TRPC6-dependent cardiac fibrosis
$726,452Jeffrey J. Saucerman · University Of Virginia · R01 · FY2025 · HL
COMMON IMMUNE CORRELATES OF RISK OF TB DISEASE IN ANIMAL MODELS AND HUMANS
$726,447Shabaana A. Khader · Washington University · R01 · FY2018 · AI
Prenatal Programming of Neonatal Asthma Susceptibility
$726,443Lester Kobzik · Harvard School Of Public Health · R01 · FY2011 · ES
Phenotyping Asthma for Bronchial Thermoplasty: Airway Smooth Muscle Structure and Function
$726,426Melissa J Suter · Massachusetts General Hospital · R01 · FY2019 · HL
Alleviation of chemotherapy-induced cardiovascular toxicity
$726,408Yanbo Fan · University Of Cincinnati · R01 · FY2024 · HL
Suppression of ERalpha in Hematopoietic Stem Cell-Derived Adipocytes Increases Adiposity via Kynurenine and the Aryl Hydrocarbon Receptor
$726,400Dwight J Klemm · University Of Colorado Denver · U54 · FY2024 · AG
Role of Inflammation in SCD-related Pain in Children with Sickle Cell Disease
$726,346Robin E Miller · Nemours Children'S Hospital, Delaware · P20 · FY2016 · GM
Exercise, Depression, and Cardiac Risk
$726,338James A. Blumenthal · Duke University · R01 · FY2010 · HL